Patent Oppositions in infection drugs industry

Explore the competitive field of infection drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in infection drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the infection drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the infection drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Bacteriotherapy For Clostridium Difficile ColitisREBIOTIXMay 19, 2026PLASSERAUD
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAMay 12, 2026SANDOZ
Functionalized Peptides As Antiviral AgentsENANTA PHARMACEUTICALSMay 6, 2026PFIZER
Ceftolozane Antibiotic CompositionsMERCK SHARP & DOHMEJan 14, 2026COPA COPENHAGEN PATENTS KS
Antibody Compositions And Methods Of Use ThereofHALOZYMEDec 22, 2025PAJARO
Antibody Compositions And Methods Of Use ThereofBRISTOL MYERS SQUIBBDec 19, 2025CAMULON
Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive DisordersAMAZENTISDec 11, 2025MICROBIOTA MED SP Z OO
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER RESEARCH CENTEROct 8, 2025BOULT WADE TENNANT

To stay ahead in the competitive infection drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the infection drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONS6
Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUMICA5
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE5
Dec 4, 2024Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCES5
Jun 7, 2023Arginine And Its Use As A T Cell ModulatorINSTITUTE FOR RESEARCH IN BIOMEDICINE4
Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE4
Jul 15, 2020Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit InhibitorsF HOFFMANN LA ROCHE4
Mar 20, 2019Methods For Treating Bowel DiseasesSALIX PHARMACEUTICALS4
Aug 22, 2018Antiviral TherapyVIIV HEALTHCARE4